Sign in
4

Changes in Ownership

Xeris Biopharma Holdings, Inc. Filed Acc 0001553595-26-000002

Shannon John Patrick Jr sold 24,907 shares at $7.08 ($176,257)

  • Shannon John Patrick Jr acquired 92,301 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shannon John Patrick Jr

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-05 Sale : show line 1 in the form −24,907 $7.08 $176,257 2,705,346 D
2026-01-05 Exercise or conversion : show line 2 in the form +64,265 $1.55 $99,611 2,769,611 D
2026-01-05 Exercise or conversion : show line 3 in the form +25,136 $1.55 $38,961 2,794,747 D
2026-01-05 Exercise or conversion : show line 4 in the form +2,900 $3.94 $11,426 2,797,647 D
Open-market sales · 24,907 sh · avg $7.08 · $176,257

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-01-05 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −64,265 0 D
2026-01-05 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −25,136 0 D
2026-01-05 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −2,900 97,100 D
Loading xslF345X05/wk-form4_1767741265.xml…